These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 18035678)
21. Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Harter P; Hahmann M; Lueck HJ; Poelcher M; Wimberger P; Ortmann O; Canzler U; Richter B; Wagner U; Hasenburg A; Burges A; Loibl S; Meier W; Huober J; Fink D; Schroeder W; Muenstedt K; Schmalfeldt B; Emons G; du Bois A Ann Surg Oncol; 2009 May; 16(5):1324-30. PubMed ID: 19225844 [TBL] [Abstract][Full Text] [Related]
22. MicroRNAs in ovarian cancer biology and therapy resistance. van Jaarsveld MT; Helleman J; Berns EM; Wiemer EA Int J Biochem Cell Biol; 2010 Aug; 42(8):1282-90. PubMed ID: 20083225 [TBL] [Abstract][Full Text] [Related]
23. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection. Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566 [TBL] [Abstract][Full Text] [Related]
24. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma. Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404 [TBL] [Abstract][Full Text] [Related]
25. [Conventional and experimental prognostic factors in ovarian cancer]. Sehouli J; Mustea A; Könsgen D; Lichtenegger W Zentralbl Gynakol; 2004 Oct; 126(5):315-22. PubMed ID: 15478050 [TBL] [Abstract][Full Text] [Related]
28. Epithelial ovarian cancer: Does the time interval between primary surgery and postoperative chemotherapy have any prognostic importance? Larsen E; Blaakaer J Acta Obstet Gynecol Scand; 2009; 88(4):373-7. PubMed ID: 19253061 [TBL] [Abstract][Full Text] [Related]
29. Surgery for elderly patients with ovarian cancer. Bäuerle MG; Kreienberg R; Volm T Curr Womens Health Rep; 2003 Feb; 3(1):39-42. PubMed ID: 12521549 [TBL] [Abstract][Full Text] [Related]
30. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma. Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318 [TBL] [Abstract][Full Text] [Related]
32. [Mechanism of multidrug resistance of ovarian cancer]. Miedzińska-Maciejewska M; Wcisło G Przegl Lek; 2002; 59(10):854-8. PubMed ID: 12632928 [TBL] [Abstract][Full Text] [Related]
33. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916 [TBL] [Abstract][Full Text] [Related]
34. Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging. Takano M; Sasaki N; Kita T; Kudoh K; Fujii K; Yoshikawa T; Kato M; Hirata J; Furuya K; Tsuda H; Kikuchi Y Oncol Rep; 2008 May; 19(5):1259-64. PubMed ID: 18425385 [TBL] [Abstract][Full Text] [Related]
35. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Aghajanian C; Barakat RR; Chi DS Gynecol Oncol; 2008 Feb; 108(2):276-81. PubMed ID: 18063020 [TBL] [Abstract][Full Text] [Related]
36. Clinical factors and biomarkers in ovarian tumors development. Vrabie CD; Petrescu A; Waller M; Dina I Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637 [TBL] [Abstract][Full Text] [Related]
37. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant. Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839 [TBL] [Abstract][Full Text] [Related]